文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

CD8 淋巴细胞在超急性治疗感染期间减轻 HIV-1 在淋巴结滤泡辅助 T 细胞中的持续存在。

CD8 lymphocytes mitigate HIV-1 persistence in lymph node follicular helper T cells during hyperacute-treated infection.

机构信息

Africa Health Research Institute (AHRI), Durban, South Africa.

HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.

出版信息

Nat Commun. 2022 Jul 12;13(1):4041. doi: 10.1038/s41467-022-31692-8.


DOI:10.1038/s41467-022-31692-8
PMID:35831418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9279299/
Abstract

HIV persistence in tissue sites despite ART is a major barrier to HIV cure. Detailed studies of HIV-infected cells and immune responses in native lymph node tissue environment is critical for gaining insight into immune mechanisms impacting HIV persistence and clearance in tissue sanctuary sites. We compared HIV persistence and HIV-specific T cell responses in lymph node biopsies obtained from 14 individuals who initiated therapy in Fiebig stages I/II, 5 persons treated in Fiebig stages III-V and 17 late treated individuals who initiated ART in Fiebig VI and beyond. Using multicolor immunofluorescence staining and in situ hybridization, we detect HIV RNA and/or protein in 12 of 14 Fiebig I/II treated persons on suppressive therapy for 1 to 55 months, and in late treated persons with persistent antigens. CXCR3 T follicular helper cells harbor the greatest amounts of gag mRNA transcripts. Notably, HIV-specific CD8 T cells responses are associated with lower HIV antigen burden, suggesting that these responses may contribute to HIV suppression in lymph nodes during therapy. These results reveal HIV persistence despite the initiation of ART in hyperacute infection and highlight the contribution of virus-specific responses to HIV suppression in tissue sanctuaries during suppressive ART.

摘要

尽管接受了抗逆转录病毒疗法(ART),但组织中的 HIV 持续存在仍是 HIV 治愈的主要障碍。对天然淋巴结组织环境中受感染的细胞和免疫反应进行详细研究,对于深入了解影响组织避难所中 HIV 持续存在和清除的免疫机制至关重要。我们比较了 14 名在 Fiebig 分期 I/II 开始治疗的个体、5 名在 Fiebig 分期 III-V 接受治疗的个体和 17 名在 Fiebig VI 及以后开始接受 ART 的晚期治疗个体的淋巴结活检中 HIV 持续存在和 HIV 特异性 T 细胞反应。通过多色免疫荧光染色和原位杂交,我们在 14 名接受抑制性治疗 1 至 55 个月的 Fiebig I/II 治疗者中的 12 名和持续存在抗原的晚期治疗者中检测到 HIV RNA 和/或蛋白。CXCR3 T 滤泡辅助细胞携带最多的 gag mRNA 转录本。值得注意的是,HIV 特异性 CD8 T 细胞反应与较低的 HIV 抗原负担相关,这表明这些反应可能有助于治疗期间淋巴结中的 HIV 抑制。这些结果揭示了尽管在超急性感染中开始了 ART,但 HIV 仍持续存在,并强调了病毒特异性反应对抑制性 ART 期间组织避难所中 HIV 抑制的贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/f698f0b661f9/41467_2022_31692_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/af0ba1fcb71e/41467_2022_31692_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/217b0f78645b/41467_2022_31692_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/c082e99289b9/41467_2022_31692_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/d0216013bd08/41467_2022_31692_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/f698f0b661f9/41467_2022_31692_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/af0ba1fcb71e/41467_2022_31692_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/217b0f78645b/41467_2022_31692_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/c082e99289b9/41467_2022_31692_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/d0216013bd08/41467_2022_31692_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76d/9279299/f698f0b661f9/41467_2022_31692_Fig5_HTML.jpg

相似文献

[1]
CD8 lymphocytes mitigate HIV-1 persistence in lymph node follicular helper T cells during hyperacute-treated infection.

Nat Commun. 2022-7-12

[2]
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

PLoS Med. 2017-11-7

[3]
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.

J Infect Dis. 2017-3-15

[4]
PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals.

Nat Med. 2016-5-30

[5]
CD32 and PD-1 Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.

J Virol. 2018-9-26

[6]
Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells.

AIDS Res Hum Retroviruses. 2000-9-20

[7]
The B-Cell Follicle in HIV Infection: Barrier to a Cure.

Front Immunol. 2018-1-25

[8]
Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells.

AIDS. 1997-7-15

[9]
Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection.

Sci Transl Med. 2019-5-22

[10]
Determinants of suboptimal CD4 T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV-1 infection.

J Int AIDS Soc. 2020-9

引用本文的文献

[1]
Early treatment and PD1 inhibition enhance HIV-specific functionality of follicular CD8+ T cells.

JCI Insight. 2025-4-8

[2]
Viral Infection and Dissemination Through the Lymphatic System.

Microorganisms. 2025-2-18

[3]
Activation of CXCR3 Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development.

J Virol. 2025-3-18

[4]
HIV-SEQ REVEALS GLOBAL HOST GENE EXPRESSION DIFFERENCES BETWEEN HIV-TRANSCRIBING CELLS FROM VIREMIC AND SUPPRESSED PEOPLE WITH HIV.

bioRxiv. 2024-12-20

[5]
Safety and practicality of an excisional lymph node study driving HIV cure research in South Africa.

Front Immunol. 2024

[6]
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.

PLoS Pathog. 2024-8

[7]
Spatial technologies to evaluate the HIV-1 reservoir and its microenvironment in the lymph node.

mBio. 2024-8-14

[8]
Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure.

Nat Rev Microbiol. 2024-6

[9]
Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy.

Elife. 2023-11-8

[10]
Viral Persistence in the Gut-Associated Lymphoid Tissue and Barriers to HIV Cure.

AIDS Res Hum Retroviruses. 2023-12-13

本文引用的文献

[1]
Hypermethylation at the CXCR5 gene locus limits trafficking potential of CD8+ T cells into B-cell follicles during HIV-1 infection.

Blood Adv. 2022-3-22

[2]
Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status.

Virulence. 2021-12

[3]
Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4 T cell recovery can harbor replication-competent HIV despite viral suppression.

Sci Transl Med. 2020-3-18

[4]
HIV Infected T Cells Can Proliferate Without Inducing Expression of the Integrated Provirus.

Front Microbiol. 2019-10-1

[5]
HIV incidence rates in adolescent girls and young women in sub-Saharan Africa.

Lancet Glob Health. 2019-11

[6]
HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy.

J Clin Invest. 2019-7-30

[7]
Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection.

Sci Transl Med. 2019-5-22

[8]
Structural topology defines protective CD8 T cell epitopes in the HIV proteome.

Science. 2019-5-3

[9]
Low levels of SIV-specific CD8+ T cells in germinal centers characterizes acute SIV infection.

PLoS Pathog. 2019-3-21

[10]
Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in Thailand.

J Acquir Immune Defic Syndr. 2018-10-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索